RAK Ceramics to sell entire pharma stake

RAK Ceramics is set to release its 55% stake in RAK Pharmaceuticals to Gulf Pharmaceuticals Industries Julphar.

A Bangladesh-UAE joint venture company listed with local stock exchanges will transfer 51,702,080 ordinary shares to RAK Pharmaceuticals at Tk7 per share (as per fair value determined by the independent valuer) totalling over Tk36.2 crore. 

The company’s board has approved the offer of Julphar and its partner(s) to acquire shares 77.5% shares of RAK Pharmaceuticals and settle its certain liabilities for $9.5m, RAK Ceramics said in a statement yesterday.

Yesterday, share prices of RAK Ceramics fell 4.4% to Tk60.9 a share at the Dhaka Stock Exchange. 

UAE-based Julphar is one of the largest pharmaceuticals manufacturers in the Middle East and North Africa, which distributes medicines to over 40 countries. 

With over 800 products produced in various dosage forms and more in the pipeline, Julphar is a stellar example of one of the UAE’s local businesses making an impact on the global stage, according to the company.

RAK Ceramics is the first company that was listed with the Bangladeshi bourses in 2010 under book building method. 

According to DSE, sponsor or director has a stake of 79.07%, institute 9.95% and public 10.98%.

Ras Al Khaimah’s ruler Sheikh Saud bin Saqr al-Qassimi owns nearly 48% and the emirate’s government holds a further 5% stakes in RAK Ceramics.